Australia: Norton Rose Fulbright gears up to give with BP MS 150 charity bike ride
Last Updated: 20 January 2014

For the first time, the global legal practice of Norton Rose Fulbright will be participating in the BP MS 150, an annual bike ride to benefit the National Multiple Sclerosis Society. The Norton Rose Fulbright team consists of 150 cyclists from more than 20 offices across the globe.

Kelly Dooley, Development Director of the National MS Society, said:

"We are delighted to have Norton Rose Fulbright participate in this year's BP MS 150. Their enthusiasm is appreciated, as their riders are coming from all around the world and will likely comprise the biggest first-year team in the ride's history."

An estimated 13,000 cyclists will take part in the two-day, 180-mile ride from Houston to Austin, Texas on April 12-13, 2014. This marks the 30th year for the BP MS 150, the largest bike ride for multiple sclerosis in North America.

Adrian Ahern, Global Chairman, Norton Rose Fulbright, said:

"By making the BP MS 150 our primary global charitable initiative for 2014, we are aiming to help increase awareness of the illness and raise money for an excellent cause. I'm proud of our international team of cyclists all of whom are eager to take on this spirited challenge in the Texas heat."

Norton Rose Fulbright, which has more than 50 offices worldwide, has formed a BP MS 150 team of lawyers and professionals from the United States, Canada, Europe, Asia, Australia, South Africa and the Middle East.

Linda Addison, US Managing Partner, Norton Rose Fulbright, said:

"We are pleased to welcome our colleagues from 24 offices worldwide to ride with us in this important event. We look forward to putting the full support of our global practice behind this exceptional charity."

Norton Rose Fulbright's team, who will fund its own travel and expenses, has begun its fundraising efforts for contributions to the National MS Society. To contribute to the BP MS 150 as part of Norton Rose Fulbright's team, please visit

A progressive neurological disease, multiple sclerosis affects more than 2 million people worldwide, mostly between 20 and 50 years old. Currently, there is no known cure. For more information on the disease and the BP MS 150 ride, please visit

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Frances Drummond, Isobel Taylor
By Frances Drummond, Sophie Lees
By David Cross, Norah Chafardet
By Claudine Salameh, Candy Lau
By Abigail McGregor, David Cross, Jacob Smit
By Dylan McKimmie, Tatiana Gotvig
By Frances Drummond, Rebecca Brenikov
By Michael French
By Elisa de Wit
By Abigail McGregor, Jehan-Philippe Wood, Greg Vickery
Font Size: